Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Baricitinib may effectively treat lichen planopilaris.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Carbon black nanoparticles can harm liver and kidney function in mice.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

DHT stops hair regrowth in mice, similar to human hair loss.

Baricitinib shows promise in treating severe hair loss.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.